A detailed history of Citigroup Inc transactions in Phibro Animal Health Corp stock. As of the latest transaction made, Citigroup Inc holds 41,122 shares of PAHC stock, worth $1.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
41,122
Previous 23,713 73.42%
Holding current value
$1.01 Million
Previous $397,000 133.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$16.39 - $22.5 $285,333 - $391,702
17,409 Added 73.42%
41,122 $925,000
Q2 2024

Aug 12, 2024

BUY
$12.44 - $18.55 $44,821 - $66,835
3,603 Added 17.92%
23,713 $397,000
Q1 2024

May 10, 2024

SELL
$10.63 - $13.68 $100,240 - $129,002
-9,430 Reduced 31.92%
20,110 $260,000
Q4 2023

Feb 09, 2024

BUY
$9.59 - $12.91 $94,365 - $127,034
9,840 Added 49.95%
29,540 $342,000
Q3 2023

Nov 09, 2023

SELL
$12.43 - $15.29 $38,408 - $47,246
-3,090 Reduced 13.56%
19,700 $251,000
Q2 2023

Aug 10, 2023

BUY
$12.92 - $15.89 $74,561 - $91,701
5,771 Added 33.91%
22,790 $312,000
Q1 2023

May 11, 2023

SELL
$13.67 - $16.37 $48,432 - $57,998
-3,543 Reduced 17.23%
17,019 $260,000
Q4 2022

Feb 09, 2023

BUY
$12.05 - $15.14 $30,594 - $38,440
2,539 Added 14.09%
20,562 $275,000
Q3 2022

Nov 10, 2022

SELL
$12.82 - $20.22 $2,422 - $3,821
-189 Reduced 1.04%
18,023 $239,000
Q2 2022

Aug 10, 2022

SELL
$17.89 - $20.47 $165,124 - $188,938
-9,230 Reduced 33.63%
18,212 $348,000
Q1 2022

May 12, 2022

BUY
$18.39 - $21.85 $54,747 - $65,047
2,977 Added 12.17%
27,442 $547,000
Q4 2021

Feb 10, 2022

BUY
$18.96 - $22.76 $102,251 - $122,744
5,393 Added 28.28%
24,465 $499,000
Q3 2021

Nov 10, 2021

BUY
$20.59 - $30.01 $392,692 - $572,350
19,072 New
19,072 $410,000

Others Institutions Holding PAHC

About PHIBRO ANIMAL HEALTH CORP


  • Ticker PAHC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 20,337,600
  • Market Cap $497M
  • Description
  • Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...
More about PAHC
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.